Market Overview:
The global pancreatic cancer diagnostic devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of pancreatic cancer, technological advancements in diagnostic devices, and rising demand for minimally invasive procedures. The global pancreatic cancer diagnostic devices market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into imaging devices, tumor biomarkers, biopsy devices, and others. Others include molecular diagnostics and liquid based cytology systems. On the basis of application,.
Product Definition:
Pancreatic cancer diagnostic devices are used to detect pancreatic cancer. They include imaging tests such as CT scans and MRI scans, and blood tests that look for certain proteins that are often released by tumors. These devices help doctors determine if a person has pancreatic cancer and whether it has spread.
Imaging:
Imaging is a procedure where the medical imaging equipment creates an image of the body part to be examined. Imaging techniques include X-ray, ultrasound, CT scan and MRI. The medical device manufacturers are focusing on developing advanced technology due to increasing demand for effective diagnostic procedures from patients and healthcare professionals.
Factors such as growing geriatric population base coupled with rising awareness levels among individuals regarding early diagnosis of cancer are expected to drive growth in imaging devices market over the forecast period.
Tumor Biomarker:
A biomarker is a substance that is produced by the body in response to an injury or foreign particle, which alerts the immune system to attack cancer cells. Biomarkers are most commonly used in oncology diagnostics and therapeutics. The most common types of biomarkers used for diagnosis include tumor/cell-derived peptides such as gastrin, insulin, vascular endothelial growth factor (VEGF), and platelet-derived growth factors (PDGF).
Application Insights:
The others segment held the largest share of the application market in 2017. This is due to an increase in demand for diagnostic devices used for other applications such as drug development and research. For instance, a new device developed by researchers from China and Germany helps identify pancreatic cancer cells at early stages using optical imaging techniques. The device is named as APFlux, which helps enhance sensitivity while identifying cancer cells in-vitro and in-vivo. Such developments are expected to drive growth over the forecast period.
On the other hand, hospitals accounted for a significant share owing to an increase in incidence rates of various cancers including pancreatic cancer across several countries globally coupled with rising awareness about early diagnosis among patients & their families affected with these diseases worldwide through various media campaigns conducted by organizations such as Pancreatic Cancer Foundation International (PCFI). These factors are expected to drive growth over the forecast period thereby contributing towards revenue generation during this period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of key players, increased government funding for pancreatic cancer research, and high incidence rate of pancreatic cancer. In addition, increasing prevalence of obesity and diabetes is also contributing towards growth in this region. According to a study published by National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK), Pancreatic Cancer Action Network (PCAN), and American Pancreatic Association (APA) in 2016, approximately 59% women and 43% men were found to be obese or overweight as compared to 40% women and 25% men who are obese or overweight according to CDC’s 2015 statistics.
Growth Factors:
- Increasing incidence of pancreatic cancer
- Rising demand for minimally invasive diagnostic devices
- Technological advancements in pancreatic cancer diagnostic devices
- Growing awareness about pancreatic cancer diagnosis and treatment options
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Pancreatic Cancer Diagnostic Devices Market Research Report
By Type
Imaging, Tumor Biomarker, Biopsy, Others
By Application
Hospitals, Clinics, Others
By Companies
Roche, GE Healthcare, Siemens, BD, Philips Healthcare, Hitachi Medical, Danaher, Abbott, Canon Medical Systems, Myriad Genetics, Qiagen, Asuragen, BioMarker Strategies
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
144
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Pancreatic Cancer Diagnostic Devices Market Report Segments:
The global Pancreatic Cancer Diagnostic Devices market is segmented on the basis of:
Types
Imaging, Tumor Biomarker, Biopsy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- GE Healthcare
- Siemens
- BD
- Philips Healthcare
- Hitachi Medical
- Danaher
- Abbott
- Canon Medical Systems
- Myriad Genetics
- Qiagen
- Asuragen
- BioMarker Strategies
Highlights of The Pancreatic Cancer Diagnostic Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Imaging
- Tumor Biomarker
- Biopsy
- Others
- By Application:
- Hospitals
- Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pancreatic Cancer Diagnostic Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pancreatic cancer diagnostic devices are medical devices used to diagnose pancreatic cancer. These devices can include a variety of tests, such as an ultrasound or CT scan.
Some of the major players in the pancreatic cancer diagnostic devices market are Roche, GE Healthcare, Siemens, BD, Philips Healthcare, Hitachi Medical, Danaher, Abbott, Canon Medical Systems, Myriad Genetics, Qiagen, Asuragen, BioMarker Strategies.
The pancreatic cancer diagnostic devices market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pancreatic Cancer Diagnostic Devices Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Pancreatic Cancer Diagnostic Devices Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Pancreatic Cancer Diagnostic Devices Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Pancreatic Cancer Diagnostic Devices Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Pancreatic Cancer Diagnostic Devices Market Size & Forecast, 2018-2028 4.5.1 Pancreatic Cancer Diagnostic Devices Market Size and Y-o-Y Growth 4.5.2 Pancreatic Cancer Diagnostic Devices Market Absolute $ Opportunity
Chapter 5 Global Pancreatic Cancer Diagnostic Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pancreatic Cancer Diagnostic Devices Market Size Forecast by Type
5.2.1 Imaging
5.2.2 Tumor Biomarker
5.2.3 Biopsy
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pancreatic Cancer Diagnostic Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pancreatic Cancer Diagnostic Devices Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pancreatic Cancer Diagnostic Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pancreatic Cancer Diagnostic Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pancreatic Cancer Diagnostic Devices Analysis and Forecast
9.1 Introduction
9.2 North America Pancreatic Cancer Diagnostic Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pancreatic Cancer Diagnostic Devices Market Size Forecast by Type
9.6.1 Imaging
9.6.2 Tumor Biomarker
9.6.3 Biopsy
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pancreatic Cancer Diagnostic Devices Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pancreatic Cancer Diagnostic Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Pancreatic Cancer Diagnostic Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pancreatic Cancer Diagnostic Devices Market Size Forecast by Type
10.6.1 Imaging
10.6.2 Tumor Biomarker
10.6.3 Biopsy
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pancreatic Cancer Diagnostic Devices Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pancreatic Cancer Diagnostic Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pancreatic Cancer Diagnostic Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pancreatic Cancer Diagnostic Devices Market Size Forecast by Type
11.6.1 Imaging
11.6.2 Tumor Biomarker
11.6.3 Biopsy
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pancreatic Cancer Diagnostic Devices Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pancreatic Cancer Diagnostic Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Pancreatic Cancer Diagnostic Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pancreatic Cancer Diagnostic Devices Market Size Forecast by Type
12.6.1 Imaging
12.6.2 Tumor Biomarker
12.6.3 Biopsy
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pancreatic Cancer Diagnostic Devices Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pancreatic Cancer Diagnostic Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pancreatic Cancer Diagnostic Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pancreatic Cancer Diagnostic Devices Market Size Forecast by Type
13.6.1 Imaging
13.6.2 Tumor Biomarker
13.6.3 Biopsy
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pancreatic Cancer Diagnostic Devices Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pancreatic Cancer Diagnostic Devices Market: Competitive Dashboard
14.2 Global Pancreatic Cancer Diagnostic Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Roche
14.3.2 GE Healthcare
14.3.3 Siemens
14.3.4 BD
14.3.5 Philips Healthcare
14.3.6 Hitachi Medical
14.3.7 Danaher
14.3.8 Abbott
14.3.9 Canon Medical Systems
14.3.10 Myriad Genetics
14.3.11 Qiagen
14.3.12 Asuragen
14.3.13 BioMarker Strategies